Literature DB >> 3044645

Pharmacogenetics of methylation: relationship to drug metabolism.

R Weinshilboum1.   

Abstract

Pharmacogenetics is the study of inherited variation in drug response. Genetic differences in drug metabolism are the most common causes for inherited variations in drug response or adverse reactions to medications. Methyl conjugation is an important pathway in the biotransformation of many drugs. Experiments performed during the past decade showed that individual variations in the activities of enzymes that catalyze S-methylation, O-methylation and N-methylation are under genetic control in human tissue. These inherited variations are responsible for individual differences in metabolism, effect, and toxicity of drugs that undergo methyl conjugation. The approach used to study the pharmacogenetics of methylation may also be applicable to the study of inherited variations in other pathways of drug metabolism.

Entities:  

Mesh:

Substances:

Year:  1988        PMID: 3044645     DOI: 10.1016/s0009-9120(88)80002-x

Source DB:  PubMed          Journal:  Clin Biochem        ISSN: 0009-9120            Impact factor:   3.281


  15 in total

Review 1.  The clinical pharmacology of 6-mercaptopurine.

Authors:  L Lennard
Journal:  Eur J Clin Pharmacol       Date:  1992       Impact factor: 2.953

2.  Methionine adenosyltransferase 2A/2B and methylation: gene sequence variation and functional genomics.

Authors:  Kendra K S Nordgren; Yi Peng; Linda L Pelleymounter; Irene Moon; Ryan Abo; Qiping Feng; Bruce Eckloff; Vivien C Yee; Eric Wieben; Richard M Weinshilboum
Journal:  Drug Metab Dispos       Date:  2011-08-03       Impact factor: 3.922

Review 3.  Extrahepatic metabolism of drugs in humans.

Authors:  D R Krishna; U Klotz
Journal:  Clin Pharmacokinet       Date:  1994-02       Impact factor: 6.447

4.  Mouse kidney histamine N-methyltransferase: assay conditions, biochemical properties and strain variation.

Authors:  M C Scott; R Guerciolini; C Szumlanski; R M Weinshilboum
Journal:  Agents Actions       Date:  1991-03

5.  Arsenic toxicity in humans: Research problems and prospects.

Authors:  D J Thomas
Journal:  Environ Geochem Health       Date:  1994-12       Impact factor: 4.609

6.  Variations in arsenic methylation capacity and oxidative DNA lesions over a 2-year period in a high arsenic-exposed population.

Authors:  Yuan-yuan Xu; Yi Wang; Xin Li; Miao He; Peng Xue; Jing-qi Fu; Hui-hui Wang; Gui-fan Sun
Journal:  Int Arch Occup Environ Health       Date:  2008-05-15       Impact factor: 3.015

7.  6-Thioguanine nucleotide accumulation in erythrocytes during azathioprine treatment for systemic connective tissue diseases: a possible index for monitoring treatment.

Authors:  K Schmiegelow; N J Kriegbaum
Journal:  Ann Rheum Dis       Date:  1993-02       Impact factor: 19.103

8.  A systems biology approach reveals the role of a novel methyltransferase in response to chemical stress and lipid homeostasis.

Authors:  Elena Lissina; Brian Young; Malene L Urbanus; Xue Li Guan; Jonathan Lowenson; Shawn Hoon; Anastasia Baryshnikova; Isabelle Riezman; Magali Michaut; Howard Riezman; Leah E Cowen; Markus R Wenk; Steven G Clarke; Guri Giaever; Corey Nislow
Journal:  PLoS Genet       Date:  2011-10-20       Impact factor: 5.917

9.  Dietary intake and arsenic methylation in a U.S. population.

Authors:  Craig Steinmaus; Kenichi Carrigan; Dave Kalman; Raja Atallah; Yan Yuan; Allan H Smith
Journal:  Environ Health Perspect       Date:  2005-09       Impact factor: 9.031

10.  Family correlations of arsenic methylation patterns in children and parents exposed to high concentrations of arsenic in drinking water.

Authors:  Joyce S Chung; David A Kalman; Lee E Moore; Michael J Kosnett; Alex P Arroyo; Martin Beeris; D N Guha Mazumder; Alexandra L Hernandez; Allan H Smith
Journal:  Environ Health Perspect       Date:  2002-07       Impact factor: 9.031

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.